Relmada Therapeutics, Inc. (RLMD)

Last Three Months

27-Jan-24 -- 26-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

5

0

3

+1

0

+2

0

+3

Two Year Chart

27-Apr-22 -- 26-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
31-Jan-24 6:29 PM View:	31-Jan-24 Purchase $109.75K	Traversa Sergio Chief Executive Officer Director		Relmada Therapeutics, Inc. - RLMD	69% 144.02K to 244.02K	0	0	--	--	Show Txns Hide Txns

31-Jan-24 6:28 PM View:	31-Jan-24 Purchase $27.94K	Shenouda Maged Chief Financial Officer		Relmada Therapeutics, Inc. - RLMD	1467% 2.23K to 34.9K	0	0	--	--	Show Txns Hide Txns

31-Jan-24 6:28 PM View:	31-Jan-24 Purchase $55.43K	Ence Chuck CA and CO		Relmada Therapeutics, Inc. - RLMD	100% 0 to 38.97K	0	0	--	--	Show Txns Hide Txns